Novonesis (Novozymes) A/S (NSIS-B) — Strategic Asset Allocation Index
Novonesis (Novozymes) A/S (NSIS-B) has a Strategic Asset Allocation Index of 89.4% as of June 2023. Strategic assets (PP&E of Dkr12.34 Billion plus long-term investments of Dkr-) total Dkr12.34 Billion, measured against net assets of Dkr13.80 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Novonesis (Novozymes) A/S Strategic Asset Allocation Index (2013–2022)
This chart shows how Novonesis (Novozymes) A/S's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 89.4%, representing strategic assets of Dkr12.34 Billion against net assets of Dkr13.80 Billion DKK. Explore cash flow conversion of Novonesis (Novozymes) A/S to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Novonesis (Novozymes) A/S (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Novonesis (Novozymes) A/S from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Novonesis (Novozymes) A/S market capitalisation.
| Year | SAAI | Strategic Assets (DKK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 84.9% | Dkr12.07 Billion | Dkr12.07 Billion | Dkr- | Dkr14.23 Billion | ▲ +1.4 pp |
| 2021 | 83.4% | Dkr10.19 Billion | Dkr10.19 Billion | Dkr- | Dkr12.21 Billion | ▼ -2.0 pp |
| 2020 | 85.5% | Dkr9.61 Billion | Dkr9.61 Billion | Dkr- | Dkr11.24 Billion | ▼ -4.0 pp |
| 2019 | 89.5% | Dkr10.27 Billion | Dkr10.21 Billion | Dkr59.00 Million | Dkr11.48 Billion | ▲ +4.1 pp |
| 2018 | 85.3% | Dkr9.76 Billion | Dkr9.70 Billion | Dkr62.00 Million | Dkr11.44 Billion | ▲ +5.3 pp |
| 2017 | 80.0% | Dkr9.01 Billion | Dkr8.93 Billion | Dkr88.00 Million | Dkr11.27 Billion | ▲ +4.5 pp |
| 2016 | 75.5% | Dkr8.87 Billion | Dkr8.64 Billion | Dkr224.00 Million | Dkr11.74 Billion | ▲ +3.1 pp |
| 2015 | 72.4% | Dkr8.39 Billion | Dkr8.16 Billion | Dkr230.00 Million | Dkr11.59 Billion | ▲ +5.4 pp |
| 2014 | 66.9% | Dkr7.55 Billion | Dkr7.50 Billion | Dkr53.00 Million | Dkr11.28 Billion | ▲ +1.9 pp |
| 2013 | 65.0% | Dkr7.19 Billion | Dkr7.13 Billion | Dkr59.00 Million | Dkr11.07 Billion | — |